Efficacy and tolerability of topical 1% menthol lotion in treatment of primary cutaneous macular amyloidosis: A pilot randomized placebo-controlled trial
Efficacy and tolerability of topical 1% menthol lotion in treatment of primary cutaneous macular amyloidosis: A pilot randomized placebo-controlled trial. // Clinical Epidemiology and Global Health. – URL: https://www.sciencedirect.com/science/article/pii/S2213398426002332?dgcid=rss_sd_all
Efficacy and tolerability of topical 1% menthol lotion in treatment of primary cutaneous macular amyloidosis: A pilot randomized placebo-controlled trial. Clinical Epidemiology and Global Health. https://www.sciencedirect.com/science/article/pii/S2213398426002332?dgcid=rss_sd_all
“Efficacy and tolerability of topical 1% menthol lotion in treatment of primary cutaneous macular amyloidosis: A pilot randomized placebo-controlled trial.” Clinical Epidemiology and Global Health.
@article{article40788,
title = {Efficacy and tolerability of topical 1\% menthol lotion in treatment of primary cutaneous macular amyloidosis: A pilot randomized placebo-controlled trial},
journal = {Clinical Epidemiology and Global Health},
url = {https://www.sciencedirect.com/science/article/pii/S2213398426002332?dgcid=rss_sd_all}
}
Publication date: November–December 2026 Source: Clinical Epidemiology and Global Health, Volume 42 Author(s): Dennis Kithinji, Fausto Ciccacci, Benjamin Welu, Harrison Ndoi, Claudia Mosconi, Carolina De Santo, Mariachiara Carestia,...
Publication date: November–December 2026 Source: Clinical Epidemiology and Global Health, Volume 42 Author(s): Alex S. Borromeo, Allan M. Manaloto, Rhealeen V. Vicedo, Jessica C. Villano, Maribel F. Valencia, Walton Wider
Publication date: November–December 2026 Source: Clinical Epidemiology and Global Health, Volume 42 Author(s): Anil C. Mathew, Alan Jose, Sebin Cherian, Kaleeswaran S, Kevin Rajiv